Bibliography

Baiersdörfer, M., Boros, G., Muramatsu, H., Mahiny, A., Vlatkovic, I., Sahin, U. & Karikó, K. 2019. A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA. Mol Ther Nucleic Acids, 15, 26-35.

Barbier, A. J., Jiang, A. Y., Zhang, P., Wooster, R. & Anderson, D. G. 2022. The clinical progress of mRNA vaccines and immunotherapies. Nature Biotechnology, 40, 840-854.

Brouze, A., Krawczyk, P. S., Dziembowski, A. & Mroczek, S. 2023. Measuring the tail: Methods for poly (A) tail profiling. Wiley Interdisciplinary Reviews: RNA, 14, e1737.

Camperi, J., Chatla, K., Freund, E., Galan, C., Lippold, S. & Guilbaud, A. 2025. Current Analytical Strategies for mRNA-Based Therapeutics. Molecules, 30, 1629.

Chaudhary, N., Weissman, D. & Whitehead, K. A. 2021. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nature Reviews Drug Discovery, 20, 817-838.

Chen, Y., Davidson, N. M., Wan, Y. K., Patel, H., Yao, F., Low, H. M., Hendra, C., Watten, L., Sim, A., Sawyer, C., Iakovleva, V., Lee, P. L., Xin, L., Ng, H. E. V., Loo, J. M., Ong, X., Ng, H. Q. A., Wang, J., Koh, W. Q. C., Poon, S. Y. P., Stanojevic, D., Tran, H.-D., Lim, K. H. E., Toh, S. Y., Ewels, P. A., Ng, H.-H., Iyer, N. G., Thiery, A., Chng, W. J., Chen, L., DasGupta, R., Sikic, M., Chan, Y.-S., Tan, B. O. P., Wan, Y., Tam, W. L., Yu, Q., Khor, C. C., Wüstefeld, T., Pratanwanich, P. N., Love, M. I., Goh, W. S. S., Ng, S. B., Oshlack, A., Göke, J. & consortium, S.-N. 2021. A systematic benchmark of Nanopore long read RNA sequencing for transcript level analysis in human cell lines. bioRxiv, 2021.04.21.440736.

Cheng, F., Wang, Y., Bai, Y., Liang, Z., Mao, Q., Liu, D., Wu, X. & Xu, M. 2023. Research Advances on the Stability of mRNA Vaccines. Viruses, 15.

Crick, F. 1970. Central Dogma of Molecular Biology. Nature, 227, 561-563.

Crick, F. H. 1958. On protein synthesis. Symp Soc Exp Biol, 12, 138-63.

Crommelin, D. J. A., Anchordoquy, T. J., Volkin, D. B., Jiskoot, W. & Mastrobattista, E. 2021. Addressing the Cold Reality of mRNA Vaccine Stability. J Pharm Sci, 110, 997-1001.

Cullis, P. R. & Hope, M. J. 2017. Lipid Nanoparticle Systems for Enabling Gene Therapies. Molecular Therapy, 25, 1467-1475.

Danecek, P., Bonfield, J. K., Liddle, J., Marshall, J., Ohan, V., Pollard, M. O., Whitwham, A., Keane, T., McCarthy, S. A., Davies, R. M. & Li, H. 2021. Twelve years of SAMtools and BCFtools. GigaScience, 10, giab008.

Ewing, B. & Green, P. 1998. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome research, 8, 186-194.

Fitzgerald, K. A. & Kagan, J. C. 2020. Toll-like Receptors and the Control of Immunity. Cell, 180, 1044-1066.

Garalde, D. R., Snell, E. A., Jachimowicz, D., Sipos, B., Lloyd, J. H., Bruce, M., Pantic, N., Admassu, T., James, P., Warland, A., Jordan, M., Ciccone, J., Serra, S., Keenan, J., Martin, S., McNeill, L., Wallace, E. J., Jayasinghe, L., Wright, C., Blasco, J., Young, S., Brocklebank, D., Juul, S., Clarke, J., Heron, A. J. & Turner, D. J. 2018. Highly parallel direct RNA sequencing on an array of nanopores. Nature Methods, 15, 201-206.

Greis, K., Kirschbaum, C., Taccone, M. I., Götze, M., Gewinner, S., Schöllkopf, W., Meijer, G., von Helden, G. & Pagel, K. 2022. Studying the Key Intermediate of RNA Autohydrolysis by Cryogenic Gas-Phase Infrared Spectroscopy. Angewandte Chemie International Edition, 61, e202115481.

Gunter, H. M., Idrisoglu, S., Singh, S., Han, D. J., Ariens, E., Peters, J. R., Wong, T., Cheetham, S. W., Xu, J., Rai, S. K., Feldman, R., Herbert, A., Marcellin, E., Tropee, R., Munro, T. & Mercer, T. R. 2023. mRNA vaccine quality analysis using RNA sequencing. Nature Communications, 14, 5663.

Gunter, H. M., Idrisoglu, S., Singh, S., Han, D. J., Ariens, E., Peters, J. R., Wong, T., Cheetham, S. W., Xu, J., Rai, S. K., Feldman, R., Herbert, A., Marcellin, E., Tropee, R., Munro, T. & Mercer, T. R. 2023. mRNA vaccine quality analysis using RNA sequencing. Nature Communications, 14, 5663.

Hassett, K. J., Higgins, J., Woods, A., Levy, B., Xia, Y., Hsiao, C. J., Acosta, E., Almarsson, Ö., Moore, M. J. & Brito, L. A. 2021. Impact of lipid nanoparticle size on mRNA vaccine immunogenicity. Journal of Controlled Release, 335, 237-246.

Hong, M.-h. 2025. What is the Polydispersity Index (PDI) in Dynamic Light Scattering (DLS)? [Online]. Malvern Panalytical. Available: https://www.malvernpanalytical.com/en/learn/knowledge-center/insights/dynamic-mine-column-in-dls-what-is-polyvariance-index-pdi. Last Updated: 19th March 2025.

Hou, X., Zaks, T., Langer, R. & Dong, Y. 2021. Lipid nanoparticles for mRNA delivery. Nature Reviews Materials, 6, 1078-1094.

Hu, C., Yu, B., Jianyang, L., Yiping, W., Qian, H., Xuanxuan, Z., Feiran, C., Miao, X., Qunying, M. & and Liang, Z. 2024. Research progress on the quality control of mRNA vaccines. Expert Review of Vaccines, 23, 570-583.

Huang, D., Li, N. & Dong, X. 2024. Advances in mRNA vaccine research in the field of quality control. Biologicals, 88, 101799.

Hutchinson, J., Schweikart, F., Shannon, R., Murthy, A., Bates, S. M., Leone, S., Nissan, T., Sideris, D., Lal, C., Button, J., Rani, R., Thom, G., Bond, N., Örnskov, E. & Trabulo, S. 2025. Physicochemical and functional assessment of messenger RNA 5′Cap-end impurities under forced degradation conditions. Molecular Therapy Nucleic Acids, 36, 102570.

Jiang, F., Zhang, J., Liu, Q., Liu, X., Wang, H., He, J. & Kang, L. 2019. Long-read direct RNA sequencing by 5'-Cap capturing reveals the impact of Piwi on the widespread exonization of transposable elements in locusts. RNA Biol, 16, 950-959.

Karikó, K., Buckstein, M., Ni, H. & Weissman, D. 2005. Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA. Immunity, 23, 165-175.

Karikó, K., Buckstein, M., Ni, H. & Weissman, D. 2005. Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA. Immunity, 23, 165-175.

Kiaie, S. H., Majidi Zolbanin, N., Ahmadi, A., Bagherifar, R., Valizadeh, H., Kashanchi, F. & Jafari, R. 2022. Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects. J Nanobiotechnology, 20, 276.

Kim, Y.-K. 2022. RNA therapy: rich history, various applications and unlimited future prospects. Experimental & Molecular Medicine, 54, 455-465.

Krause, M., Niazi, A. M., Labun, K., Torres Cleuren, Y. N., Müller, F. S. & Valen, E. 2019. tailfindr: alignment-free poly(A) length measurement for Oxford Nanopore RNA and DNA sequencing. Rna, 25, 1229-1241.

Li, H. 2014. seqtk: Toolkit for processing sequences in FASTA/Q formats [Online]. Available: https://github.com/lh3/seqtk. Last Updated: 1/6/2025.

Li, H. 2018. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics, 34, 3094-3100.

Lorenz, R., Bernhart, S. H., Höner zu Siederdissen, C., Tafer, H., Flamm, C., Stadler, P. F. & Hofacker, I. L. 2011. ViennaRNA Package 2.0. Algorithms for Molecular Biology, 6, 26.

Malburet, C., Carboni, A., Guinamand, S., Naik, H. & Fertier-Prizzon, S. 2024. mRNA extraction from lipid nanoparticles. Journal of Chromatography A, 1714, 464545.

Mikkola, S., Lönnberg, T. & Lönnberg, H. 2018. Phosphodiester models for cleavage of nucleic acids. Beilstein Journal of Organic Chemistry, 14, 803-837.

Morais, P., Adachi, H. & Yu, Y. T. 2021. The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines. Front Cell Dev Biol, 9, 789427.

Nakamura, T., Kawai, M., Sato, Y., Maeki, M., Tokeshi, M. & Harashima, H. 2020. The Effect of Size and Charge of Lipid Nanoparticles Prepared by Microfluidic Mixing on Their Lymph Node Transitivity and Distribution. Molecular Pharmaceutics, 17, 944-953.

Oivanen, M., Kuusela, S. & Lönnberg, H. 1998. Kinetics and Mechanisms for the Cleavage and Isomerization of the Phosphodiester Bonds of RNA by Brønsted Acids and Bases. Chemical Reviews, 98, 961-990.

Parhiz, H., Atochina-Vasserman, E. N. & Weissman, D. 2024. mRNA-based therapeutics: looking beyond COVID-19 vaccines. The Lancet, 403, 1192-1204.

Parhiz, H., Atochina-Vasserman, E. N. & Weissman, D. 2024. mRNA-based therapeutics: looking beyond COVID-19 vaccines. The Lancet, 403, 1192-1204.

Quinlan, A. R. & Hall, I. M. 2010. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics, 26, 841-842.

Schoenmaker, L., Witzigmann, D., Kulkarni, J. A., Verbeke, R., Kersten, G., Jiskoot, W. & Crommelin, D. J. A. 2021. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability. Int J Pharm, 601, 120586.

Slaoui, M. & Hepburn, M. 2020. Developing Safe and Effective Covid Vaccines — Operation Warp Speed’s Strategy and Approach. New England Journal of Medicine, 383, 1701-1703.

Stephenson, W., Razaghi, R., Busan, S., Weeks, K. M., Timp, W. & Smibert, P. 2022. Direct detection of RNA modifications and structure using single-molecule nanopore sequencing. Cell Genomics, 2, 100097.

Tinari, S. 2021. The EMA covid-19 data leak, and what it tells us about mRNA instability. BMJ, 372, n627.

Uddin, M. N. & Roni, M. A. 2021. Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines. Vaccines (Basel), 9.

USP-NF. 2022. Analytical procedures for mRNA vaccine quality (draft guidelines) [Online]. Available: https://www.uspnf.com/notices/analytical-procedures-mrna-vaccines-20220210.

Wang, J. & Maldonado, M. A. 2006. The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases. Cell Mol Immunol, 3, 255-61.

Wang, Y., Zhao, Y., Bollas, A., Wang, Y. & Au, K. F. 2021. Nanopore sequencing technology, bioinformatics and applications. Nature biotechnology, 39, 1348-1365.

Wayment-Steele, H. K., Kim, D. S., Choe, C. A., Nicol, J. J., Wellington-Oguri, R., Watkins, A. M., Parra Sperberg, R. A., Huang, P.-S., Participants, E. & Das, R. 2021. Theoretical basis for stabilizing messenger RNA through secondary structure design. Nucleic Acids Research, 49, 10604-10617.

World Health Organization. 2021. Evaluation of the quality, safety and efficacy of messenger RNA vaccines for the prevention of infectious diseases: regulatory considerations [Online]. Available: https://www.who.int/publications/m/item/evaluation-of-the-quality-safety-and-efficacy-of-messenger-rna-vaccines-for-the-prevention-of-infectious-diseases-regulatory-considerations.